Divalproex Sodium Capsule, Delayed Release
Product Images NDC 62332-821

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 62332-821). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex-figr1.jpg (Divalproex Figr1)

A line graph comparing the percentage reduction in CPS rate for patients treated with Divalproex Sodium versus placebo. The y-axis shows percentage reduction in CPS rate ranging from -100% to 100%, indicating worsening to improvement, and the x-axis shows the percentage of patients from 100% to 0%. Two curves are displayed, one solid line for Divalproex Sodium and one dashed line for placebo, illustrating patient response distribution.*

FDA Label Image

Divalproex-figr2.jpg (Divalproex Figr2)

A line graph comparing the percentage reduction in CPS rate between high dose and low dose groups. The x-axis represents the percentage of patients, decreasing from 100% to 0%, while the y-axis shows the percentage reduction in CPS rate from -100% (worsening) to 100% (improvement), with 0% indicating no change. The solid line represents the high dose group, and the dashed line represents the low dose group.*

FDA Label Image

Divalproex-ifu-p2.jpg (Divalproex Ifu P2)

The image shows a white, delayed-release oral capsule for Divalproex sodium, marked with the imprint 'D9' and an arrow symbol above it. This capsule corresponds to the 125 mg strength manufactured by Alembic Pharmaceuticals Inc.*

FDA Label Image

Divalproex-ifu-p3.jpg (Divalproex Ifu P3)

An illustration showing a handgun with an arrow circling its grip and a capsule labeled with "D9" and an incomplete word "THIS E" overlaying the handgun's grip area. The image appears instructional or symbolic, combining the firearm and capsule elements in a stylized manner.*

FDA Label Image

Divalproex-ifu-p4.jpg (Divalproex Ifu P4)

An illustration showing a delayed release capsule being opened, with small round beads or pellets pouring out. The capsule is labeled with the text "D9." This image likely demonstrates the capsule's delayed release formulation and content delivery.*

FDA Label Image

Divalproex-ifu-p5.jpg (Divalproex Ifu P5)

An illustration showing a person holding a spoon near their mouth as if about to take oral medication. The image is likely demonstrating oral administration of the drug.*

FDA Label Image

100 Sprinkle Capsules (Divalproex mg 125)

Divalproex Sodium Delayed-Release Capsules, USP 125 mg by Alembic Pharmaceuticals Inc. This label is for a 100 count of sprinkle capsules. It includes storage conditions, dispensing instructions, manufacturer details for Alembic Pharmaceuticals, Limited and Alembic Pharmaceuticals, Inc., and a barcode with NDC 62332-821-31.*

FDA Label Image

Divalproex-structure.jpg (Divalproex Structure)

Chemical structure diagram of divalproex sodium, showing the molecular arrangement including sodium ion and valproate complex within parentheses indicating polymeric or repeating units.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.